查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929221

生物来源1,2-己二醇市场：依功能特性、纯度等级、应用、终端用户产业及通路划分，全球预测（2026-2032年）

Bio-based 1,2-Hexanediol Market by Functional Property, Purity Grade, Application, End Use Industry, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物基 1,2-己二醇市值将达到 1.3275 亿美元，到 2026 年将成长至 1.4252 亿美元，到 2032 年将达到 1.958 亿美元，复合年增长率为 5.70%。

关键市场统计数据
基准年 2025 1.3275亿美元
预计年份：2026年 1.4252亿美元
预测年份 2032 1.958亿美元
复合年增长率 (%) 5.70%

关于生物基1,2-己二醇的重要指南，重点介绍其技术优势、在配方中的作用以及对永续产品开发的战略意义

生物基1,2-己二醇正逐渐成为配方师追求多功能且环境影响较小的理想选择，优于传统的石油基替代品。其理化性质赋予其抗菌功效、良好的溶剂相容性和润肤特性，使其适用于多种个人护理和工业配方。日益严格的监管审查和不断增长的消费者需求正促使製造商评估生物基二醇，将其视为满足更严格的安全性和永续性要求，同时保持产品外观和稳定性的实用途径。

不断变化的永续性优先事项、日益严格的监管以及生产创新如何重塑生物基特种二醇的供应链和配方策略

受永续性倡议、日益严格的监管以及配方理念演变的影响，生物基1,2-己二醇的市场格局正在迅速变化。品牌所有者和采购团队的永续性倡议正在加速对可再生原料和低碳製程生产材料的需求，而这种趋势正在重塑整个价值链的筹资策略。因此，企业优先考虑那些能够提供透明的碳排放和材料可追溯性、第三方认证以及符合企业环境目标的经审核供应链的供应商。

2025 年关税的综合影响迫使企业将采购业务迁回国内，调整供应商结构，并采取策略性供应链弹性措施。

2025年关税的实施为全球特种配料供应链带来了显着的摩擦，促使各方重新审视筹资策略、定价方法和供应商关係。进口中间体和成品关税导致成本上升，促使买家寻求更贴近市场的替代供应方案（包括区域采购和本地生产），以降低关税风险并减少前置作业时间波动。同时，许多采购和销售团队也重新评估了供应商合同，以期在数量承诺和价格调整机制方面拥有更大的柔软性。

精准細項分析，以明确应用特定需求、纯度预期、功能角色以及原料采用的分布动态

详细的市场細項分析揭示了影响生物基1,2-己二醇在不同应用和通路中应用的不同需求驱动因素和技术要求。按应用领域划分，市场评估涵盖其作为化妆品防腐剂、护髮产品、口腔护理产品和护肤系统的作用。化妆品防腐剂应用进一步细分为抗真菌、抗菌和抗氧化子应用。护髮产品分为护髮素、髮膜、护髮精华和洗髮精。口腔护理产品包括漱口水和牙膏，而护肤则包括润肤露、脸部脸部保养、足部护理和护手霜。这种应用层面的细分影响纯度预期、多功能性要求和配方范围。防腐剂应用需要强大的抗菌性能，而润肤剂和保湿剂则优先考虑感官和保湿特性。

区域比较分析说明，美洲、欧洲、中东和非洲以及亚太地区的监管要求、製造能力和采购重点存在差异。

区域趋势在生物基1,2-己二醇的筹资策略、认证重点和製造地方面发挥着至关重要的作用。美洲地区的特点是：品牌主导的对永续采购的强劲需求、积极的私部门永续发展倡议以及对快速产品创新週期的重视。这些因素促使供应商提供透明的供应链文件，并与配方师紧密合作，以进行快速测试和规模化生产。该地区的法规环境强调清晰的安全数据和标籤规范，从而加快了化妆品级和药品级产品的认证流程。

决定公司在供应多层次、符合监管要求的生物基特种二醇方面取得成功的关键策略和竞争优势

生物基1,2-己二醇领域的竞争动态体现了策略定位的综合作用，强调技术专长、认证资格和供应链透明度。领先的供应商透过投资生产技术来提升原料的柔软性并改善杂质特性，从而创造出满足化妆品、工业和製药需求的广泛产品组合。随着企业寻求缩短认证时间并在规模化生产过程中共用技术风险，原材料生产商、契约製造和配方商之间的策略伙伴关係日益普遍。

为采购、研发和销售团队提供可操作的、优先的策略建议，以建立有韧性的采购系统、加快认证速度并加强监管合规性。

产业领导者应优先考虑切实可行的措施，以平衡即时业务连续性和长期策略定位。首先，多元化筹资策略，纳入区域供应商和契约製造合作伙伴，将确保生产连续性所需的替代原料来源，同时降低关税和物流风险。此外，认证多种纯度等级并建立清晰的内部验收标准，将加速技术应用，缩短新配方上市时间。

我们采用了一种透明的混合方法研究途径，结合了从业者访谈、技术检验和第二手资料的检验，以确保得出可靠的实践结论。

本分析的调查方法结合了与领域专家和从业人员的直接对话、有针对性的技术检验以及严谨的二次三角验证，以确保其有效性和相关性。关键资讯来源包括对配方工程师、供应链经理、法规专家、契约製造製造商和技术服务负责人的结构化访谈，以了解实际应用中的限制因素、认证时间表和产品性能预期。这些从业人员的观点对于理解纯度等级、功能特性和通路对产品推广应用的影响至关重要。

清晰且全面的结论，重点阐述了将生物基原料的优势转化为商业性成功所需的技术、监管和供应链的优先事项。

总之，生物基1,2-己二醇完美契合了性能驱动型配方需求和日益增长的永续性期望。其多功能特性使其成为配方师的宝贵资产，帮助他们精简成分列表，同时满足抗菌、润肤和保湿需求。日益严格的法规、消费者对产品来源的要求以及生产製造技术的创新，共同为市场参与企业带来了机会和挑战，要求他们在供应商选择、纯度等级认证和文件记录方面采取严谨的方法。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章生物来源的1,2-己二醇市场依功能特性划分

  • 抗菌剂
  • 润肤剂
  • 保湿霜
  • 溶剂

第九章生物来源的1,2-己二醇市场（依纯度等级划分）

  • 化妆品级
  • 工业级
  • 医药级

第十章生物来源的1,2-己二醇市场（依应用领域划分）

  • 化妆品防腐剂
    • 抗真菌剂
    • 抗菌
    • 抗氧化剂
  • 护髮
    • 护髮素
    • 髮膜
    • 护髮精华液
    • 洗髮精
  • 口腔护理
    • 漱口水
    • 牙膏
  • 护肤
    • 身体乳液
    • 脸部保养
    • 足部护理
    • 护手霜

第十一章生物来源1,2-己二醇市场（依最终用途产业划分）

  • 化妆品和个人护理
  • 家用清洁剂
  • 工业清洗
  • 製药

第十二章生物来源的1,2-己二醇市场（依通路划分）

  • 直销
  • 经销商
  • 电子商务

第十三章生物来源）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章生物来源1,2-己二醇市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国生物来源1,2-己二醇市场概况

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国生物来源1,2-己二醇市场

第十七章 中国生物来源1,2-己二醇市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arkema SA
  • Ashland Global Holdings Inc.
  • BASF SE
  • Celanese Corporation
  • Clariant AG
  • CM Fine Chemicals, Inc.
  • Croda International Plc
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Hefei TNJ Chemical Co., Ltd.
  • Huntsman International LLC
  • Innospec Inc.
  • Jiangsu Dynamic Chemical Co., Ltd.
  • Jubilant Life Sciences Limited
  • KCC Corporation
  • Lonza Group AG
  • Minasolve GmbH
  • Mitsubishi Chemical Corporation
  • Penta Manufacturing Company
  • Sabinsa Corporation
  • SEPPIC SAS
  • Solvay SA
  • Stepan Company
  • Symrise AG
  • The Lubrizol Corporation
Product Code: MRR-0A380695170C

The Bio-based 1,2-Hexanediol Market was valued at USD 132.75 million in 2025 and is projected to grow to USD 142.52 million in 2026, with a CAGR of 5.70%, reaching USD 195.80 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 132.75 million
Estimated Year [2026] USD 142.52 million
Forecast Year [2032] USD 195.80 million
CAGR (%) 5.70%

An essential orientation to bio-based 1,2-hexanediol that clarifies its technical advantages, formulation roles, and strategic relevance for sustainable product development

Bio-based 1,2-hexanediol has emerged as a high-impact ingredient for formulators seeking multifunctional performance combined with lower environmental footprint compared with traditional petrochemical alternatives. Its physicochemical profile supports antimicrobial efficacy, solvent compatibility, and emollient behavior, making it suitable for a broad set of personal care and industrial formulations. As regulatory scrutiny and consumer demand intensify, manufacturers are evaluating bio-derived diols as practical tools to meet tighter safety and sustainability expectations while maintaining product aesthetics and stability.

Over recent years, the ingredient's adoption has been driven by an intersection of technical performance and supply-chain evolution. Advances in fermentation and green-chemistry conversion routes have improved feedstock flexibility and reduced reliance on virgin petrochemicals. Concurrently, formulators are prioritizing multifunctional ingredients to simplify formulations, reduce SKU complexity, and achieve regulatory compliance more efficiently. These dynamics position bio-based 1,2-hexanediol not merely as a niche alternative but as a strategic component in product portfolios where safety claims, preservation efficacy, and sensory properties matter.

Transitioning toward broader adoption requires a clear understanding of technical trade-offs, purity-grade implications, and end-user expectations. Therefore, this report emphasizes the ingredient's role across functional applications, highlights supply-chain and policy developments that influence sourcing, and lays out practical guidance for product developers and commercial stakeholders aiming to integrate bio-based 1,2-hexanediol in robust, compliant formulations.

How evolving sustainability priorities, regulatory tightening, and production innovations are reshaping supply chains and formulation strategies for bio-based specialty diols

The landscape for bio-based 1,2-hexanediol is shifting rapidly under the influence of sustainability commitments, regulatory tightening, and evolving formulation philosophies. Sustainability commitments from brand owners and procurement teams are accelerating demand for ingredients produced via renewable feedstocks and lower-carbon processes, and this emphasis is reshaping sourcing strategies across the value chain. As a result, companies are reprioritizing suppliers that can demonstrate transparent carbon and feedstock tracing, third-party certifications, and audited supply chains that align with corporate environmental targets.

Regulatory frameworks are also evolving, prompting manufacturers to pre-emptively reformulate or validate ingredient use ahead of new compliance requirements. This has a cascading effect on product development cycles: formulators now favor multifunctional ingredients that reduce additive counts while maintaining efficacy and safety. Concurrently, consumer-facing claims around clean beauty and ingredient provenance have driven marketing and R&D teams to invest in raw material audits and cradle-to-gate assessments.

Technological innovation is enabling new production pathways, including biocatalysis and fermentation-derived intermediates, which increase feedstock flexibility and lower reliance on constrained petrochemical routes. These innovations, coupled with strategic partnerships between specialty chemical producers and downstream brands, are driving faster commercialization and diversification of grade offerings. Consequently, the marketplace is witnessing a convergence of environmental goals, regulatory pressure, and technical progress that together are reconfiguring how bio-based 1,2-hexanediol is developed, certified, and adopted.

The aggregated consequences of 2025 tariff introductions that compelled sourcing localization, supplier realignment, and strategic supply-chain resilience measures

The imposition of tariffs in 2025 has introduced material friction into global supply chains for specialty ingredients, prompting a re-evaluation of sourcing strategies, pricing approaches, and supplier relationships. Tariff-driven cost increases for imported intermediates and finished ingredients have encouraged buyers to explore closer-to-market supply alternatives, including regional sourcing and localized manufacturing, to mitigate duty exposure and reduce lead-time volatility. In parallel, many procurement and commercial teams reassessed supplier contracts to incorporate greater flexibility on volume commitments and price adjustment mechanisms.

Tariffs also amplified the importance of feedstock and route diversification; firms with the capacity to pivot between bio-based feedstocks or to substitute feedstocks that qualify for more favorable duty treatments gained an operational advantage. As a consequence, partnerships that enable toll manufacturing, domestic tolling agreements, or co-located production facilities became more attractive as a means to preserve margin and ensure continuity of supply. The cumulative effect of these adjustments has been a shift toward more resilient, regionally balanced supply chains designed to withstand both policy volatility and logistical disruption.

Moreover, the tariff environment accelerated supplier consolidation and strategic alignment across the value chain. Larger players sought to secure capacity and integrate vertically, while smaller specialty producers focused on niche technical differentiation and high-touch service models. For formulators and brand owners, the tariff-driven landscape underscored the need for deeper commercial collaboration with ingredient suppliers, clearer contractual risk-sharing frameworks, and proactive regulatory monitoring to anticipate future policy shifts that could affect both ingredient pricing and availability.

Precision segmentation insights that clarify application-specific requirements, purity expectations, functional roles, and distribution dynamics for ingredient adoption

A granular view of segmentation reveals distinct demand drivers and technical requirements that shape adoption of bio-based 1,2-hexanediol across applications and channels. In application terms, the market is assessed across cosmetic preservative roles, hair care formulations, oral care products, and skin care systems, with cosmetic preservative use further delineated into antifungal, antimicrobial, and antioxidant sub-uses, hair care subdivided into conditioner, hair mask, hair serum, and shampoo formats, oral care explored via mouthwash and toothpaste applications, and skin care addressed across body lotion, facial care, foot care, and hand cream. This application-level granularity influences purity expectations, multi-functionality requirements, and formulation windows, as preservative duties demand robust antimicrobial performance while emollient or humectant roles prioritize sensory and hydration properties.

When considered by end-use industry, the ingredient is contextualized within cosmetics and personal care, household cleaning, industrial cleaning, and pharmaceutical applications, each of which imposes unique regulatory and technical constraints. Functional-property segmentation frames the argument around antimicrobial agent, emollient, humectant, and solvent performance, and this perspective helps R&D teams prioritize grades or co-ingredients to meet targeted efficacy and sensorial goals. Purity-grade distinctions into cosmetic grade, industrial grade, and pharmaceutical grade are critical for compliance and validation processes; higher purity grades command stricter testing, documentation, and traceability protocols that influence supplier selection and cost-to-qualify timelines.

Finally, distribution channel segmentation-direct sales, distributors, and e-commerce-shapes how procurement teams access the ingredient, the scale of minimum order quantities, and the support services available, such as technical service, regulatory dossiers, and logistical solutions. Taken together, these segmentation lenses provide a practical framework for product teams to match technical requirements with supplier capabilities, reduce time-to-market, and design go-to-market approaches that align with channel characteristics and end-use regulatory expectations.

Comparative regional intelligence that explains how regulatory expectations, manufacturing capacity, and buyer priorities differ across Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics play a decisive role in shaping sourcing strategies, certification priorities, and manufacturing footprints for bio-based 1,2-hexanediol. In the Americas, the landscape is characterized by strong brand-driven demand for sustainable sourcing, active private-sector sustainability commitments, and an emphasis on rapid product innovation cycles; these drivers incentivize suppliers to provide transparent supply-chain documentation and to partner closely with formulators for rapid trials and scale-up. The regulatory environment in this region places a premium on clear safety dossiers and labelling practices, which accelerates qualification processes for cosmetic-grade and pharmaceutical-grade offerings.

Europe, Middle East & Africa presents a heterogeneous regulatory and commercial environment where stringent chemical safety frameworks and consumer expectations around sustainability and traceability elevate compliance burdens. In this region, access to certification pathways, life-cycle assessment data, and rigorous third-party testing often determines procurement decisions. Manufacturers active across these markets typically prioritize early engagement with regulatory experts and invest in supply-chain traceability to meet retailer and regulator requirements. The market dynamics also reward technical differentiation, such as novel bio-production pathways and documented reductions in environmental impact.

Asia-Pacific combines large-scale manufacturing capabilities with rapidly growing demand from both domestic brands and export-oriented producers. In this region, cost-competitive production, proximity to feedstock sources, and efficient logistics networks drive supplier selection, while growing regulatory sophistication in key markets is prompting higher expectations for quality assurance and purity documentation. Firms operating regionally balance the need for competitive cost structures with investments in technical service, color and odor control, and scalable quality management systems to support cross-border commercialization.

Critical company-level strategies and competitive differentiators that determine success in supplying multi-grade, compliance-driven bio-based specialty diols

Competitive dynamics in the bio-based 1,2-hexanediol space reflect a mix of strategic positioning that emphasizes technical expertise, certification credentials, and supply-chain transparency. Leading suppliers are differentiating through investments in production technologies that expand feedstock flexibility and improve impurity profiles, thereby enabling broader grade portfolios that meet cosmetic, industrial, and pharmaceutical requirements. Strategic partnerships between raw-material producers, toll manufacturers, and formulators are becoming more common as companies seek to shorten qualification timelines and share technical risk during scale-up.

Quality assurance and documentation have emerged as decisive competitive levers. Companies that offer comprehensive regulatory dossiers, third-party testing, and traceability data capture a higher level of trust with brand teams and procurement departments. Meanwhile, firms that provide responsive technical support-ranging from lab-scale trial assistance to stability testing and preservative claim substantiation-tend to secure longer-term commercial relationships. Mergers, targeted capacity investments, and selective vertical integration are being used by some players to guarantee feedstock access and to shield margins from policy-driven input-cost variation.

Service models also matter; suppliers that can deliver customized packing, flexible minimum order quantities, and integrated logistics solutions reduce barriers for smaller formulators and regional laboratories. As buyers prioritize suppliers who can align on sustainability goals, those investing in transparent carbon and feedstock reporting systems are better positioned to capture projects with high regulatory or retailer scrutiny. Ultimately, competitive success in this ingredient category is tied to the combination of technical excellence, robust compliance documentation, and the ability to tailor supply arrangements to customer needs.

Actionable, prioritized strategic recommendations for procurement, R&D, and commercial teams to build resilient sourcing, faster qualification, and stronger regulatory alignment

Industry leaders should prioritize a set of pragmatic initiatives that balance immediate operational resilience with long-term strategic positioning. First, diversify sourcing strategies to include regional suppliers and toll-manufacturing partners to mitigate tariff exposure and logistics risk while preserving alternative feedstock pathways for production continuity. Simultaneously, qualify multiple purity grades and establish clear in-house acceptance criteria to speed technical adoption and reduce time-to-market for new formulations.

Invest in verification and documentation systems that support sustainability claims and regulatory compliance. Detailed life-cycle assessments, supplier audits, and traceability reports will strengthen commercial negotiations and meet the expectations of procurement teams and retailers. Align R&D investments toward multifunctional formulations that leverage the ingredient's antimicrobial, emollient, and humectant properties, thereby reducing formulation complexity and enhancing cost-efficiency. Engage early with regulatory experts and testing laboratories to preempt compliance hurdles, particularly for pharmaceutical-grade applications.

Finally, adopt customer-centric commercial approaches by offering flexible packaging and logistics options, technical support packages that include hands-on stability or preservation testing, and tiered pricing models that reflect batch sizes and long-term commitments. These actions will protect margin, accelerate qualification cycles, and build deeper supplier-client relationships that are resilient to policy shifts and market volatility.

A transparent, mixed-methods research approach combining practitioner interviews, technical verification, and secondary triangulation to ensure robust and actionable findings

The research methodology underlying this analysis combined primary engagement with subject-matter experts and practitioners, targeted technical verification, and rigorous secondary-source triangulation to ensure validity and relevance. Primary inputs included structured interviews with formulators, supply-chain managers, regulatory specialists, toll manufacturers, and technical service professionals to capture real-world constraints, qualification timelines, and product performance expectations. These practitioner perspectives were instrumental in understanding how purity grades, functional properties, and distribution channels influence adoption.

Technical verification included laboratory-level reviews of functional performance, impurity profiles, and document audits for regulatory dossiers to assess the practical implications of grade differentiation. Secondary research comprised peer-reviewed literature on bio-based production routes, public regulatory guidance, patent landscape analysis, and industry white papers to map technological trajectories and policy developments. Data synthesis employed cross-validation techniques to reconcile potentially divergent inputs and to highlight consensus viewpoints and outlier observations.

Quality controls for this study included corroboration of interview insights against documented regulatory criteria, verification of supplier claims through available conformity documentation, and scenario mapping to illustrate plausible impacts of policy and tariff changes. Methodological transparency was maintained throughout, with clear delineation of assumptions, interview sample characteristics, and validation protocols to ensure that readers can understand the basis for the insights and recommendations provided.

A clear, integrated conclusion stressing technical, regulatory, and supply-chain priorities necessary to translate bio-based ingredient advantages into commercial success

In summary, bio-based 1,2-hexanediol sits at the intersection of performance-driven formulation needs and accelerating sustainability expectations. Its multifunctional properties make it a valuable asset for formulators seeking to consolidate ingredient lists while meeting antimicrobial, emollient, and humectant requirements. The convergence of regulatory tightening, consumer demand for provenance, and production innovations creates both opportunity and complexity for market participants, demanding a disciplined approach to supplier selection, purity-grade qualification, and documentation.

Companies that proactively diversify sourcing, invest in robust verification and technical support, and align product development with regulatory trajectories will be best positioned to convert ingredient advantages into competitive products. Tariff and policy volatility underscore the importance of flexible supply-chain arrangements and deeper commercial collaboration across the value chain. By acting on the strategic recommendations outlined here-prioritizing resilience, technical readiness, and transparent sustainability reporting-organizations can reduce adoption friction, accelerate product development cycles, and capture value in a marketplace increasingly focused on safe, effective, and verifiably sustainable ingredients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-based 1,2-Hexanediol Market, by Functional Property

  • 8.1. Antimicrobial Agent
  • 8.2. Emollient
  • 8.3. Humectant
  • 8.4. Solvent

9. Bio-based 1,2-Hexanediol Market, by Purity Grade

  • 9.1. Cosmetic Grade
  • 9.2. Industrial Grade
  • 9.3. Pharmaceutical Grade

10. Bio-based 1,2-Hexanediol Market, by Application

  • 10.1. Cosmetic Preservative
    • 10.1.1. Antifungal
    • 10.1.2. Antimicrobial
    • 10.1.3. Antioxidant
  • 10.2. Hair Care
    • 10.2.1. Conditioner
    • 10.2.2. Hair Mask
    • 10.2.3. Hair Serum
    • 10.2.4. Shampoo
  • 10.3. Oral Care
    • 10.3.1. Mouthwash
    • 10.3.2. Toothpaste
  • 10.4. Skin Care
    • 10.4.1. Body Lotion
    • 10.4.2. Facial Care
    • 10.4.3. Foot Care
    • 10.4.4. Hand Cream

11. Bio-based 1,2-Hexanediol Market, by End Use Industry

  • 11.1. Cosmetics & Personal Care
  • 11.2. Household Cleaning
  • 11.3. Industrial Cleaning
  • 11.4. Pharmaceuticals

12. Bio-based 1,2-Hexanediol Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E-Commerce

13. Bio-based 1,2-Hexanediol Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bio-based 1,2-Hexanediol Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bio-based 1,2-Hexanediol Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bio-based 1,2-Hexanediol Market

17. China Bio-based 1,2-Hexanediol Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arkema S.A.
  • 18.6. Ashland Global Holdings Inc.
  • 18.7. BASF SE
  • 18.8. Celanese Corporation
  • 18.9. Clariant AG
  • 18.10. CM Fine Chemicals, Inc.
  • 18.11. Croda International Plc
  • 18.12. DuPont de Nemours, Inc.
  • 18.13. Evonik Industries AG
  • 18.14. Hefei TNJ Chemical Co., Ltd.
  • 18.15. Huntsman International LLC
  • 18.16. Innospec Inc.
  • 18.17. Jiangsu Dynamic Chemical Co., Ltd.
  • 18.18. Jubilant Life Sciences Limited
  • 18.19. KCC Corporation
  • 18.20. Lonza Group AG
  • 18.21. Minasolve GmbH
  • 18.22. Mitsubishi Chemical Corporation
  • 18.23. Penta Manufacturing Company
  • 18.24. Sabinsa Corporation
  • 18.25. SEPPIC SAS
  • 18.26. Solvay SA
  • 18.27. Stepan Company
  • 18.28. Symrise AG
  • 18.29. The Lubrizol Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIMICROBIAL AGENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIMICROBIAL AGENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIMICROBIAL AGENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY EMOLLIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY EMOLLIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY EMOLLIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HUMECTANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HUMECTANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HUMECTANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SOLVENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SOLVENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SOLVENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIFUNGAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIFUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIMICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIMICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIOXIDANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIOXIDANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ANTIOXIDANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY CONDITIONER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY CONDITIONER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY CONDITIONER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR MASK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR MASK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR MASK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SHAMPOO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SHAMPOO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SHAMPOO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY MOUTHWASH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY MOUTHWASH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY TOOTHPASTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY TOOTHPASTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY TOOTHPASTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY BODY LOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY BODY LOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY BODY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FACIAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FACIAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FACIAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FOOT CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FOOT CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FOOT CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAND CREAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAND CREAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAND CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HOUSEHOLD CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HOUSEHOLD CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HOUSEHOLD CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY INDUSTRIAL CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY INDUSTRIAL CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY INDUSTRIAL CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 231. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 244. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY FUNCTIONAL PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY COSMETIC PRESERVATIVE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY ORAL CARE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA BIO-BASED 1,2-HEXANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)